Sort
23,748 grants matching “melanoma”
Gasdermin E and pyroptosis in cancer
$504,066Judy Lieberman · Boston Children'S Hospital · R01 · FY2020 · CA
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
$504,040Noriyuki Kasahara · University Of Miami School Of Medicine · R01 · FY2017 · CA
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C
$504,006K Jin Kim · Galaxy Biotech, Llc · R44 · FY2012 · CA
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
$503,987William E Gillanders · Washington University · P50 · FY2018 · CA
FUNCTIONAL ANALYSIS OF UVEAL MELANOMA DORMANCY TO IDENTIFY ANTIMETASTATIC THERAPIES
$503,950Albert Einstein College Of Medicine · · FY2021 · Defense Health Agency
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma.
$503,863George V Aslanidi · University Of Minnesota · R01 · FY2024 · CA
INTEGRINS AND OCULAR ANGIOGENESIS
$503,617Scripps Research Institute · R01 · FY2001 · EY
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$503,520David Reardon · Brigham And Women'S Hospital · P01 · FY2024 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$503,480Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2024 · CA
Computational Approaches for RNA StructureFunction Determination
$503,448Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$503,337Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
$503,337Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects
$503,244John B Sunwoo · Stanford University · R01 · FY2019 · DE
DRIVER MUTATIONS THAT SHAPE TUMORIGENESIS AND IMMUNORESISTANCE OF MELANOMA. NEW AWARD.
$503,136The General Hospital Corporation · · FY2020 · Defense Health Agency
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$503,134Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Primary Project
$503,119Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · U54 · FY2011 · CA
DKK2 regulates NK activation and tumor immunity
$503,046Dianqing Wu · Yale University · R01 · FY2022 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$502,945Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2016 · CA
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$502,902Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
The regulation of melanocyte stem cells by Wnt signaling
$502,883Mayumi Ito · New York University School Of Medicine · R01 · FY2023 · AR
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
$502,859J. Silvio Gutkind · University Of California, San Diego · R01 · FY2024 · CA
The Adenosinergic Pathway in Tumor-derived Exosomes
$502,792Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$502,765David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Selective inhibition of nitric oxide synthase for multiple indications
$502,671Richard B Silverman · Northwestern University · R01 · FY2015 · GM
Membrane-based immunotherapy for triple negative breast cancer- a partnered approach
$502,655Periasamy Selvaraj · Emory University · R01 · FY2016 · CA